Invo Fertility, INC. 8-K Filing
Ticker: IVF · Form: 8-K · Filed: Dec 17, 2025 · CIK: 1417926
Sentiment: neutral
Filing Stats: 1,364 words · 5 min read · ~5 pages · Grade level 12.9 · Accepted 2025-12-17 09:05:44
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value IVF The Nasdaq Stock Mark
- $750,000 — inic") for a combined purchase price of $750,000 (the "Purchase Price"). Unless specifie
- $350,000 — ry 27, 2026, Buyer shall pay the Clinic $350,000 in cash, less a holdback amount of $150
- $150,000 — ,000 in cash, less a holdback amount of $150,000 (the "Holdback Amount"), and $400,000 o
- $400,000 — f $150,000 (the "Holdback Amount"), and $400,000 of the Company's preferred stock to be
- $10,000 — he Purchase Price shall be increased by $10,000. The Clinic provides direct treatment
Filing Documents
- form8-k.htm (8-K) — 48KB
- ex10-1.htm (EX-10.1) — 450KB
- ex99-1.htm (EX-99.1) — 15KB
- 0001493152-25-028070.txt ( ) — 773KB
- ivf-20251215.xsd (EX-101.SCH) — 3KB
- ivf-20251215_lab.xml (EX-101.LAB) — 33KB
- ivf-20251215_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 3KB
01 Other Events
Item 8.01 Other Events On December 17, 2025, the Company issued a press release announcing the execution of the APA. A copy of the press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference. Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 10.1 Asset Purchase Agreement dated December 15, 2025. 99.1 Press release dated December 17, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document.) -3-
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: December 17, 2025 INVO FERTILITY, INC. /s/ Steven Shum Steven Shum Chief Executive Officer -4-